Why it was recalled
Defective Container: slow leakage under the cap
Product description
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Lot numbers, UPCs & expiration codes
Lot # 118920, exp. January 2024.
Where it was sold
Nationwide in the USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1139-2023
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Aug 23, 2023
- FDA report date
- Sep 6, 2023
- Quantity
- 11,350 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Contract Pharmaceuticals Limited Canada
Original FDA data
Every field from FDA enforcement report D-1139-2023, exactly as published.
Show all FDA fields
- City
- Mississauga
- Status
- Terminated
- Country
- Canada
- Event ID
- 92922
- Address
- 7600 East Danbro Cres
- Code information
- Lot # 118920, exp. January 2024.
- Report date
- Sep 6, 2023
- Product type
- Drugs
- Recall number
- D-1139-2023
- Classification
- Class III
- Recalling firm
- Contract Pharmaceuticals Limited Canada
- Product quantity
- 11,350 bottles
- Termination date
- Aug 6, 2025
- Reason for recall
- Defective Container: slow leakage under the cap
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
- Distribution pattern
- Nationwide in the USA.
- Recall initiation date
- Aug 23, 2023
- Initial firm notification
- Letter
- Center classification date
- Aug 29, 2023